This week’s research roundup features: The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses. 

This list includes updates posted to mayocliniclabs.com during the month of June.

Top highlights include: CMS rolls out new payment model on improving cancer treatments, Mayo Clinic Waseca breaks ground on renovation project, Wearables are collecting a flood of data - an ambitious new study of pregnancy aims to prove that's valuable for health.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with ¬¬¬¬¬Dr. Jeffrey Winters, Chair of the Division of Transfusion Medicine, and Professor of Laboratory Medicine and Pathology at Mayo Clinic, to talk about the new AABB guidelines for convalescent plasma.

This July, Mayo Clinic’s Neuroimmunology Laboratory will showcase its revolutionary approach to autoimmune neurology testing at the American Academy of Neurology (AAN) Summer Conference: Autoimmune Neurology and Neurology Year in Review in San Francisco. During the meeting, Mayo Clinic Laboratories representatives will highlight our growing list of disease-specific tests and discuss how results can inform decision-making and improve treatment outcomes.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the latest developments in monkeypox, the reality of living in the age of pandemics, and the importance of testing and public-private partnerships.

As director of Regulatory Affairs for the Department of Laboratory Medicine and Pathology, Shannon Bennett helps safeguard Mayo Clinic’s reputation for quality care by ensuring that its clinical laboratories operate at the highest level of regulatory compliance.

Featured Abstract: Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.

Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small insertions or deletions, and copy number variants on approximately 20,000 genes, enabling precision answers to accurately diagnose, manage, and treat patients with identified inherited illness.

Due to the Independence Day holiday, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

Today's highlights include: Moderna says updated vaccine works better against Omicron, FDA advisors back Novavax COVID shot, and disparities remain in opioid treatment access.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice consider the recent uptick in cases of monkeypox and what labs can do to help facilitate accurate diagnosis of it and other viral infections.

This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.

PACE/State of CA/State of FL - This “phlebotomy webinar” will walk learners through the quality improvement methodology and describe PDSA cycle interventions that were implemented in this unit which successfully reduced the amount of canceled labs due to specimen integrity.

Featured abstract: Nuclear GSK-3β and oncogenic KRas lead to the retention of pancreatic ductal progenitor cells phenotypically similar to those seen in IPMN.